DPP-4(Dipeptidyl peptidase-4) inhibitor Sitagliptin Phosphate Hydrate study to the inhibition of extension atherosclerosis
Not Applicable
Not yet recruiting
- Conditions
- Type2 diabetes mellitus (borderline)
- Registration Number
- JPRN-UMIN000004881
- Lead Sponsor
- Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Has a history of allergy to Sitagliptin Phosphate Hydrate 2.Has a history of severe ketosis, diabetic coma and type1 diabetes mellitus 3.Has a history of severe renal insufficiency (hemodialysis or peritoneal dialysis patients) 4.Has a history of severe infection, perioperative term and severe wound 5.Has a overt systemic disease (liver cirrhosis, thyroid gland disease and nephrotic syndrome and so on) 6.Is not appropriate in the investigators' opinion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method